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Synopsis:
Optical coherence tomography based definitions for the diagnosis of 
lamellar macular hole, macular pseudohole and epiretinal membrane 
foveoschisis are suggested. Consistent terminology is seminal to the study
of such macular conditions and may significantly improve their clinical 
management.
3ABSTRACT
Background:  A consensus on an optical coherence tomography (OCT) 
definition of lamellar macular hole (LMH) and similar conditions is needed.
Methods: The panel reviewed relevant peer-reviewed literature to reach 
a consensus on LMH definition and to differentiate LMH from other similar 
conditions.
Results: The panel reached a consensus on the definition of 3 clinical 
entities: LMH, epiretinal membrane (ERM) foveoschisis and macular 
pseudohole (MPH). LMH definition is based on 3 mandatory criteria and 3 
optional anatomical features. The 3 mandatory criteria are the presence 
of irregular foveal contour, the presence of a foveal cavity with 
undermined edges, and the apparent loss of foveal tissue. Optional 
anatomical features include the presence of epiretinal proliferation, the 
presence of a foveal bump and the disruption of the ellipsoid line. ERM 
foveoschisis definition is based on 2 mandatory criteria: the presence of 
ERM and the presence of schisis at the level of Henle’s fiber layer. Three 
optional anatomical features can also be present: the presence of 
microcystoid spaces in the inner nuclear layer (INL), an increase of retinal 
thickness, and the presence of retinal wrinkling. MPH definition is based 
on 3 mandatory criteria and 2 optional anatomical features. Mandatory 
criteria include the presence of a foveal sparing ERM, the presence of a 
steepened foveal profile and an increased central retinal thickness. 
Optional anatomical features are the presence of microcystoid spaces in 
the INL and a normal retinal thickness.
Conclusions: The use of the proposed definitions may provide uniform 
language for clinicians and future research.
4Introduction: 
The transformative shift from slit-lamp biomicroscopy to high 
resolution spectral-domain optical coherence tomography (OCT) has 
dramatically improved the ability to study foveal microanatomy.1 
However, with this change in diagnostic methods, the original slit lamp-
based definition of lamellar macular hole (LMH) has become outdated, and
there is no new definition that has achieved consensus amongst 
clinicians.2-3 Currently, in the literature the term ‘‘lamellar macular hole’’ 
(LMH) refers to a wide spectrum of retinal conditions characterized by a 
break in the inner fovea and an irregular foveal contour.1 This broad and 
inclusive terminology includes several distinct clinical entities, with 
different morphology and pathophysiology.1-4 This overbroad and 
imprecise definition could negatively influence clinical practice, 
complicate inter-study comparisons, and hinder the decision between 
observation and intervention in the management of these conditions. 
Recent histopathology and clinical reports have provided novel 
insights into the morphologic  features of LMH which could help 
distinguish different pathological forms from each other.1-10 Therefore, 
acknowledging that it was the appropriate time for a clear definition of 
LMH based on new retinal imaging, a panel of vitreo-retinal experts 
collected and evaluated published evidence on the subject and merged 
this information to reach a consensus on an OCT-based diagnosis and 
definition of what constitutes  LMH.  Furthermore, by updating the 
definition of LMH, the group sought to differentiate it from other overtly 
similar, but distinguishable entities.
Methods:
An international panel of vitreo-retinal experts was selected by the 2
panel organizers (JPH and RT), with the aim of providing a clear, up-to-
date OCT-based definition of LMH. All experts have a history of relevant 
publications and/or research contribution on the subject, participation in 
other consensus efforts, and availability to participate. The assigned goal 
for this first work was to propose definitions meant to facilitate clinical 
practice and patient management by guiding differential diagnosis 
between LMH and other similar macular lesions, and to removing 
ambiguity from communication among clinicians, thus improving the 
5relevance of future studies and inter-study comparisons. This work was 
approved by the Institutional Review Board of the University of California 
Los Angeles, and the research project adhered to the tenets of the 
Declaration of Helsinki. 
At the beginning of the review process, to identify the retinal 
imaging features and definitions used in the key publications to date, an 
initial selection of the relevant articles dealing with diagnosis or definition 
of LMH was performed on Pubmed 
(https://www.ncbi.nlm.nih.gov/pubmed/) using the following search 
strategy, with no language restriction:  lamellar AND macular AND (hole 
OR holes), last accessed April 15, 2018. Then the panel organizers 
selected from the initial list major peer-reviewed articles all published in 
journals in the first-quartile score (Q1, top 25% of the impact factor 
distribution) addressing the issue of lamellar macular hole definition and 
classification.1-28 Articles in which the main outcome was the analysis of 
surgical results were excluded in the selection process. The selection was 
then reviewed by the panel organizers. The panel approved 28 papers 
(details bellow) to be used as basis for the following steps. 
As a second step, to assess the agreement of the panelists to detect
a range of image based features of various foveal defects, and gauge 
their ability to subdivide lesions based on the available definitions, the 
panel organizers developed two questionnaires named work package 1 
and 2 (WP1 and 2). WP 1 and 2, of 12 and 8 cases respectively, included 
all OCT images (B-scans, en-face and/or 3D reconstruction) and some 
cases also included color fundus images, of LMH, ERM, foveoschisis and 
lesions currently defined as macular pseudoholes, as well as a series of 
open-ended questions directed to the panel members. WP1 and 2 were 
distributed among all the panel members, and their answers, based on the
selected literature and their opinion, collected and collated by the panel 
organizers. 
As a third step, all collected information from the responses was 
provided to the panel members and used to guide discussion among them
during two group meetings. To reach a consensus on terminology and 
definitions, the Delphi method, also known as Estimate-Talk-Estimate, was
applied. At the end of the process, a consensus among the panel 
members was reached on new terminology and definitions. This led to a 
proposal to differentiate 3 previously confused maculopathies: LMH, 
epiretinal membrane foveoschisis and macular pseudohole.
Results:
The literature search strategy retrieved 242 peer-reviewed articles. 
The panel organizers reviewed all articles titles and abstracts and initially 
selected 22 major articles focusing on LMH and macular pseudohole 
diagnosis and/or definitions. After review of the initial selection, 6 other 
articles were added by panel members and accepted by the entire group. 
A total of 28 articles were eventually selected to be used as base for 
discussions. 
Panel members agreed that the proposed definitions of LMH, 
epiretinal membrane foveoschisis, and macular pseudohole should be 
6primarily based on OCT, with scans centered in the foveal region. The 
decision to use OCT (B-scans and en-face images) as the primary 
examination modality was based on its ability to image foveal 
microstructure, its availability and its non-invasive nature. For each 
definition, mandatory and optional diagnostic criteria were identified. Each
OCT feature, or criteria used in disease definitions, was also defined by 
the group to help proper interpretation and diagnosis.
Terminology of OCT features 
The panel agreed to the use of the following terminology to describe
OCT features. 
Epiretinal membrane (ERM): The definition of ERM was specified 
to differentiate from epiretinal proliferation described below. On OCT 
scans, an ERM was considered as the presence of an irregular and 
hyperreflective line over the inner limiting membrane (ILM), often 
associated with signs of wrinkling of the underlying retina, with the 
frequent presence of hyporeflective spaces between the epiretinal 
membrane and the ILM (supplementary file 1). The term “premacular 
membrane” was proposed by some panel members as more relevant 
since membranes in question are always anterior to the macula, when 
“epi”, meaning adjacent, does not specify which side of the retina is 
affected. Nonetheless, use of “ERM” for further descriptions won the 
consensus for the sake of familiarity. It is important to note that the use of
the term “ERM” as an OCT finding does not always imply the presence of 
a discernable macular pucker in the fundus. 
Epiretinal proliferation: The OCT appearance of thick, 
homogeneous and iso-reflective epiretinal material over the ILM (figure 1) 
has to be distinguished from the hyperreflective ERM described earlier. 
Epiretinal proliferation is fully in contact with the ILM, with no 
hyporeflective spaces between the two anatomical structures, in 
distinction to ERM. It should be noted that the iso-reflective epiretinal 
proliferation as seen by OCT is often covered by a thin hyperreflective 
line. A quick inexpert look at the OCT scan can then misperceive the thick 
iso-reflective epiretinal material as part of the retina and the anterior 
reflection as the ERM. However, the identification of the retinal layers and 
the reflective ILM may help in reconsidering the diagnosis. 
Beyond differences in OCT appearance between ERM and epiretinal 
proliferation, increasing evidences in the literature justify differentiating 
them. Actually,  epiretinal proliferation was first described as “thick” or 
“thicker” ERM, and later renamed “lamellar-macular hole associated 
epiretinal proliferation” (LHEP) by Pang et al, as it was believed to be 
present only in association with LMH.6 However, subsequent reports 
showed that the presence of this epiretinal material is not exclusive to 
LMH, as it can be found as well in full-thickness macular holes, in the 
presence of posterior uveitis, and even associated with macular pucker.11 
Histopathology studies demonstrated that, in contrast to the epiretinal 
membranes that cause macular pucker, such epiretinal proliferation has 
little or no contractile properties, suggesting that epiretinal proliferation 
7and ERM are two different entities.5 Therefore, to describe the epiretinal 
proliferation as “thick” ERM may be misleading as it does not highlight the
relevant pathophysiologic differences among these two distinct 
conditions.  Finally, to name it “proliferation” appears appropriate, as 
there is significant evidence that the amount of this material increases 
over time, suggesting cellular proliferation.13-15 Epiretinal membranes are 
also cellular proliferation on the surface of the retina, but the usual term 
ERM does not include the term “proliferation” allowing to use it for these 
proliferations. The location of the visible proliferation on the anterior 
surface of the retina would justify the use of the term “premacular”. 
However, here also to conform to the published nomenclature, in 
particular LHEP, it was accepted just to drop the “lamellar-macular hole 
associated” from LHEP as it is not precise anymore (described in other 
macular conditions) and keep the remaining “epiretinal proliferation” part 
for the subsequent descriptions.
Foveal “bump”: a bulge of retinal tissue in the foveal center, 
usually surrounded by foveal cavities with undermined edges (defined 
below), is common in LMH. It may represent “spared” retinal tissue not 
involved in the pathophysiological process which caused retinal tissue loss
or some proliferation.  
Foveal cavity with undermined edges: Intraretinal 
hyporeflective spaces which could affect all retinal layers and may be 
confluent. They may probably correspond to areas of tissue loss as they 
do not cause an increase in retinal thickness. Further, as seen with 
structural SD-OCT the retinal layers appear to be eroded rather than 
displaced. In case of LMH, they are often connected with the vitreous 
cavity through a break in the inner fovea (figure 2).2 On en-face OCT 
segmented at the level of the INL they appear often as a single large 
central, homogeneous hyporeflective area with petaloid outer border 
(supplementary file 2,A). The term “undermined edge” is used in 
dermatology to describe skin ulcers which appear similar in morphology to
LMH as seen with OCT.29 
Cystoid spaces: the presence of round/elliptical intraretinal 
hyporeflective cystoid spaces, occasionally confluent and mainly located 
in the inner nuclear layer (INL) and outer plexiform layer (OPL). The 
distinction between foveal cavity with undermined edges and cystoid 
spaces is important, as, beside the opening to the vitreous, it also implies 
probable differences in the pathophysiology of these two conditions. While
foveal cavity with undermined edges refers to the formation of a 
hyporeflective space within the retina, presumably caused by tissue loss, 
the presence of retinal cystoid spaces suggests the creation of spaces 
primary due to displacement of cells rather that loss of retinal tissue. The 
en-face OCT segmented at the level of the INL and ONL illustrates multiple
hyporeflective roundish spaces disposed in a classic petaloid area. Small 
cystoid spaces almost exclusively located in the INL (supplementary file 
2,B and 3) are often referred to as microcystoid spaces. Müller cell 
dysfunction has been suggested to play a role in microcystoid spaces 
development.30
8Foveoschisis:  The use of the term was proposed by the panel for 
an OCT feature analogous to what is found in myopic foveoschisis. When 
present in a non-myopic eye, on structural OCT, foveoschisis appears as a 
separation (“schisis”) between foveal retinal layers, typically the outer 
nuclear layer (ONL) and OPL, at the level of the Henle’s fiber layer (HFL). It
is likely caused by the action of mechanical forces (i.e. vitreomacular 
traction or epiretinal membrane) over the central fovea.31 As in myopic 
foveoschisis, inner and outer retina are typically connected through 
intraretinal, mainly beveled, hyperreflective bridges of tissue, which may 
correspond to stretched and verticalized Müller cells bodies and which are
intermingled by hyporeflective intraretinal spaces (figure 3). The en-face 
imaging segmented at the level of the HFL can show stretched 
hyporeflective spaces disposed in radial pattern over the macular region, 
mimicking the disposition of z-shaped Müller cells in the central macula 32 
The appearance on OCT is then different from round shape cystoid spaces
and foveal cavity with undermined edges as described above. 
 Lamellar macular hole
In the original  description by Gass in  1976, LMH was identified with
slit lamp biomicroscopy as a partial-thickness macular lesion resulting 
from cystoid macular edema.16 Later, it was proposed that such a 
definition of LMH should be revised, as the terminology derived from slit 
lamp biomicroscopy may be outdated and imprecise in the era of OCT 
imaging.3 The first OCT-based description using the term LMH was 
published in 1998 and included an irregular foveal contour, an intraretinal 
split of the foveal edges, and a near normal perifoveal retinal thickness.17 
With the advent of SD-OCT imaging, other authors refined the definition of
this lesion as the presence of irregular foveal contour, break in the inner 
fovea, intraretinal split and intact foveal photoreceptors.1, 10 Some authors 
proposed that only lesions with apparent tissue loss should be named 
LMH, while other similar-looking changes of the fovea related to ERM 
contraction with no suggestion of tissue loss on OCT imaging could be 
called "macular pseudohole with stretched edges".3 The presence or 
absence of tissue loss was thought to be critical to the distinction between
“true” LMH and other entities referred to as macular pseudohole with 
stretched or lamellar dissection of edges by authors.3 Similarly, it was 
suggested that the lesions diagnosed as LMH may consist of two distinct 
clinical entities, named "degenerative" and "tractional" LMH.2 The former, 
was considered a partial thickness defect in the inner fovea, with foveal 
cavity with undermined edges, the presence of epiretinal proliferation, 
frequent disruption of the outer retina and in some cases, the appearance 
of a central "bump" of presumably spared foveal tissue (supplementary 
file 4). The latter was characterized by the presence of foveoschisis at the 
level of Henle’s fiber layer, the presence of a tractional ERM, intact 
photoreceptors, and microcystoid macular edema in the INL. The presence
or absence of tissue loss was not considered in the distinction between 
degenerative and tractional LMH.2,4
After evaluation of the previously mentioned reports and the 
relevant literature, the group of retinal experts proposed a definition of 
9LMH based on 3 mandatory and 3 optional diagnostic criteria. The 
diagnosis of LMH should be limited to cases that fulfill all the mandatory 
diagnostic criteria when optional criteria can also help confirm the 
diagnosis. 
The mandatory criteria for the diagnosis of LMH were the presence 
of: 1. irregular foveal contour (i.e. abnormal, non-linear shape of the 
foveal pit contour); 2. foveal cavity with undermined edges; 3. Presence of
at least one other sign evoking a loss of foveal tissue, i.e. pseudo-
operculum, thinning of the foveal at its center, or around. Associated 
pathologic changes can include: 1. epiretinal proliferation; 2. foveal bump;
3. ellipsoid line disruption. 
As single scan of OCT may miss some features, sufficiently dense 
central volume acquisition (macular raster with at least inter-scan 
distances of 120µm) or radial scans is required to allow for adequate 
analysis of all components that may not be present all around the center 
of the fovea. En-face OCT reconstructions is also very useful to confirm 
changes in the foveolar area.
Such a definition is similar to what was previously considered as 
“true” LMH or a "degenerative" LMH.2-3 The concept of foveal cavity with 
undermined edges was considered by the panel as the key features of 
LMH. This OCT finding was considered a presumed sign of retinal cell loss 
that can be present at onset or may worsen with time and is differentiated
from other entities such as cystoid spaces and foveoschisis as defined 
above. 
While OCT remains superior to any other imaging modalities in the 
diagnosis of LMH, this entity can be seen on fundus color photos as 
roundish usually central lesion, slightly darker than the surrounding retina,
on Blue-Fundus Autofluorescence (B-FAF) as roundish usually central 
lesion slightly brighter than the surrounding retina, on SLO near-infrared 
imaging it also appears as a dark roundish central lesion, and on 
fluorescein angiography as hyperfluorescent at early phases (no masking 
of choriocapillary fluorescence) with no late hyperfluorescence (figure 4). 
There is increasing evidence that the central fovea has unique features 
with specialized Müller cells and Henle’s fibers containing macular 
pigment.15,33,34 The alteration (disappearance and/or displacement) of 
macular pigment may then explain change in fluorescence on fundus B-
FAF imaging. 4,9   
The presence of epiretinal proliferation was considered as a optional
criterion for the diagnosis of LMH as it is not always present in such 
lesions, in particular at early stages.2,11 Nevertheless, according to the 
published literature, the presence of epiretinal proliferation was 
considered an important anatomical and functional landmark, as it has 
been associated with lower visual acuity and higher rates of 
photoreceptors disruption.2,6-7,13 
Similarly, the presence of ellipsoid line disruption was considered as 
an optional criterion. Although this outer retinal alteration is often visible 
with OCT in LMH, in many lesions the ellipsoid line is intact. Moreover, 
outer retinal disruption is a common feature in many macular pathologies.
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 Mechanical tangential traction does not seem to be critical in the 
development of LMH as signs of retinal traction are rarely evident, in 
contradistinction to ERM Foveoschisis.8 Moreover, the epiretinal 
proliferation has shown little or no contractile properties as confirmed by 
en-face OCT (supplementary file 5).5
The presence of a foveal “bump” has been considered by many as a
distinctive feature of LMH.2 It can be related and connected to epiretinal 
proliferation. However, in some lesions it may not be present. 
The pathophysiology of LMH is still largely unknown. Its occurrence, 
possibly in some cases after posterior vitreous detachment and 
sometimes with the presence of a pseudo-operculum on posterior vitreous
cortex, suggests partial avulsion of foveal tissue. Although the term 
“degenerative” may suggest an additional slow progressive mechanism 
leading to additional loss of retinal tissue, this concept is still largely 
speculative, and no related terminology was included by the panel. 
Beside posterior vitreous detachment-related LMH we discuss in this
paper, which may can be called primary LMH, there may be other causes 
leading to other types of lamellar lesions involving the foveolar area, with 
some variants in the appearances of inner and outer lamellar defects 
depending of the cause. Such lesions may originate from unroofed cystoid
macular edema,16 end-stage age-related macular degeneration,21 MacTel 
type 2,22 Solar retinopathy,23 Tamoxifen retinopathy,35 and partial closure 
of full-thickness macular hole.36 These lesions filling mandatary signs may 
be named LMH but be referred to as “non-primary LMH” and should be 
considered as different at least by etiology as they may not respond 
similarly to possible treatments of primary LMH. 
Epiretinal Membrane Foveoschisis 
The presence of foveoschisis in association with an ERM is the most 
common cause of misdiagnosis of LMH. It is now proposed to be named as
"Epiretinal membrane foveoschisis" and diagnosed according to 2 
mandatory and 3 optional diagnostic criteria, as summarized below and 
illustrated in figure 5. Similar to LMH, the diagnosis of ERM foveoschisis 
requires fulfillment of all mandatory criteria. 
The mandatory criteria for the diagnosis of ERM foveoschisis were 
the presence of: 1. contractile ERM; 2. foveoschisis at the level of Henle’s 
fiber layer. 
The optional criteria were the presence of: 1. microcystoid spaces in
the INL; 2. retinal thickening; 3. retinal wrinkling.
ERM foveoschisis is included in this classification system as it could 
lead in some cases to an irregular foveal contour that can be confused 
with LMH. In the literature these cases have been also previously 
distinguished but referred to as "tractional" LMH and "macular pseudohole
with stretched edges".2-3 The panel considered that the word "lamellar 
hole" for such lesions is confusing. These lesions are likely caused by 
mechanical displacement and separation of inner and outer retina as in 
foveoschisis, as supported by a recent biomechanical model.31 
According to this hypothesis, tissue loss in epiretinal membrane 
foveoschisis may be negligible. Blue FAF often illustrates hyperreflective 
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patterns in epiretinal membrane foveoschisis, a finding which can also be 
correlated with tissue loss in the published literature.37 However, the 
pathophysiologic correlation of hyper autofluorescence in these lesions is 
uncertain and is probably caused by the displacement of macular pigment
in the central macula, rather than loss of tissue.
As the interpretation of Blue FAF is still controversial, the authors 
considered this imaging modality not reliable enough to be included in the
diagnostic criteria.    
The OCT finding of a contractile ERM, best appreciated on en-face 
OCT, appeared to be critical in the development of foveoschisis and, 
therefore, considered as mandatory diagnostic criteria.8 Moreover, it 
represents a key distinction from LMH, in which signs of traction upon the 
retina are infrequently seen. Another distinction in the presence of vitreo-
papillary adhesion, which is four times more prevalent than in LMH.8
The terminology “epiretinal membrane foveoschisis” differentiates 
this condition from myopic foveoschisis or stellate non-hereditary 
idiopathic foveomacular retinoschisis, in which a significant tractional ERM
may not be found. Further, the term underscores a causative association 
between the presence of a tractional ERM and the development of 
foveoschisis. 
Microcystoid spaces in the INL are a frequent finding in tractional 
disorders such as vitreo-macular traction syndrome, ERM and macular 
hole, and are often present in ERM foveoschisis.30 Similarly, retinal 
thickening and wrinkling very often present may sometimes not be 
visualized in ERM foveoschisis and were then considered as minor 
diagnostic criteria. 
Macular pseudohole
Similar to the original definition of LMH, the initial concept of 
macular pseudohole was developed by Allen and Gass using slit-lamp 
biomicroscopy, and referred to a macular lesion characterized by the 
presence of an ERM sparing the fovea, with the creation of invaginated or 
heaped foveal edges.18 The term “pseudohole” was used clinically when 
fundus examination shows a discrete reddish, round or oval lesion that 
mimics a full-thickness macular hole. Slit-lamp examination of the macula 
can sometimes result in a false diagnosis of full-thickness macular hole, 
but OCT imaging can easily distinguish between the two entities in most 
cases.  macular pseudohole is then only a peculiar appearance of an 
epiretinal membrane on fundus examination. However, as the terminology
is commonly used, the group found it useful to formalize an OCT definition
for it as a differential diagnosis to LMH. 
The OCT diagnosis of macular pseudohole is based on 3 mandatory 
and 2 optional criteria, as summarized below and illustrated in 
supplementary file 6. 
Mandatory criteria are: 1. foveal center sparing ERM; and 2. retinal 
thickening and 3. verticalized or steepened foveal profile. 
Minor criteria are: 1. presence of microcystoid spaces in the INL; 2. 
near normal central foveal thickness.
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Such a definition is similar to that previously proposed by the 
International Vitreomacular Traction Study Group.24
Perhaps the defining feature of macular pseudohole is the presence 
of a concomitant foveal center sparing ERM and verticalized foveal edges. 
This configuration causes the distortion of the foveal contour into a shape 
with a steep slope; The ERM is supposed to have a causative role in the 
development of a pseudohole, as it displaces the retina toward the foveal 
center via centripetal tangential traction. The result is invagination of the 
perifoveal retina into a shape that mimics a partial thickness hole.
Conclusions 
Consensus has been reached for the definitions of 3 conditions that 
are often confused in the literature: lamellar macular hole, macular 
pseudohole and epiretinal membrane foveoschisis. These proposed 
definitions should help to better distinguish these 3 conditions with the 
aim of providing uniform language for clinicians and researchers to use 
when discussing the subject. 
Of note, some patients may present with features common to the 3 
different conditions. The existence of “mixed” lesions such as LMH with 
ERM, particularly as both seem to be due to anomalous posterior vitreous 
detachment, is intrinsic to almost any classification system, and does not 
negate the terminology presented herein.
We fully recognize that these definitions may evolve with improved 
imaging, observation, and further study. Thus, classification systems 
should be dynamic and evolve with advances in our knowledge of 
diseases and their underlying pathophysiologic mechanisms. However, a 
consensus nomenclature at this time will facilitate collaboration for future 
research to improve patient management.
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FIGURE CAPTIONS
Figure 1. Epiretinal proliferation. In this case of lamellar macular hole,
the epiretinal proliferation is visible with spectral-domain optical 
coherence tomography as a thick, homogeneous and iso-reflective 
preretinal material over the internal limiting membrane (white arrows). 
The epiretinal proliferation is often covered by a thin hyperreflective line.
Figure 2. Foveal cavity with undermined edges. Lamellar macular 
holes are characterized by the presence of foveal cavity with undermined 
edges, seen with spectral-domain optical coherence tomography as large, 
often confluent intraretinal hyporeflective cystoid spaces, connected with 
the vitreous cavity through a break in the inner fovea. The foveal cavity 
with undermined edges can potentially affect all retinal layers.
Figure 3. Foveoschisis.  Foveoschisis is visible with spectral-domain 
optical coherence tomography as a sharp separation between the outer 
nuclear and outer plexiform layers, at the level of the Henle fiber layer. 
Intraretinal hyperreflective bridges of tissue (white star), possibly 
stretched Müller cells bodies, connect inner and outer retina, and are 
separated by hyporeflective intraretinal spaces.
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Figure 4. Lamellar macular hole: multimodal imaging. A. Optical 
coherence tomography imaging. Optical coherence tomography 
illustrates a typical lamellar macular hole, with irregular foveal contour, 
foveal cavity with undermined edges and the presence of epiretinal 
proliferation. The ellipsoid line and the external limiting membrane appear
disrupted. B. Color fundus photo. Lamellar macular hole appears as a 
roundish central lesion in the fovea, which is slightly darker than the 
surrounding retina. C. Infrared imaging. Similarly to color fundus 
imaging, lamellar macular hole appears as a darker area in the central 
fovea. D. Fluorescein angiography: early phase. At early phases 
fluorescein angiography illustrates a slightly hyperfluorescent lesion 
slightly temporal to the central fovea. E. Fluorescein angiography: late
phase. At late phases, the hyperfluorescence is still present but gradually
it fades out. F. Blue-Fundus Autofluorescence. Lamellar macular hole 
is visible as a para-central area of increased autofluorescence. G: En-face
optical coherence tomography. Segmentation at the level of the 
vitreoretinal interface. No signs of traction like folds and retinal wrinkling 
are visible in the macular area. The lamellar macular hole appears as a 
dark circular area just temporal to the fovea. 
Figure 5: Epiretinal membrane foveoschisis: multimodal Imaging. 
A. Optical coherence tomography imaging. Optical coherence 
tomography illustrates a typical epiretinal membrane foveoschisis, with 
irregular foveal contour, a contractile preretinal membrane and the 
presence of foveoschisis at the level of the Henle fiber layer. B. Color 
fundus photo. Epiretinal membrane foveoschisis appears as a roundish 
central lesion in the fovea, which is slightly darker than the surrounding 
retina. A contractile epiretinal membrane is visible as a yellowish area 
over the macula, associated with wrinkling of the underlying retina C. 
Infrared imaging. With infrared imaging, retinal wrinkles are clearly 
visible. D. Blue-Fundus Autofluorescence. Epiretinal membrane 
foveoschisis is visible as a central area of increased signal. E. En-face 
optical coherence tomography. Segmentation at the level of the 
vitreoretinal interface. Prominent signs of traction, folds and retinal 
wrinkling are appreciable in the macular area. The epiretinal membrane 
foveoschisis appears as a dark area centered in the fovea.
